Quote:
Originally Posted by madisongrrl
Just reading between the lines of the article it is likely that an IND has been filed and no holds have been placed by the FDA - especially if Merck Sorono has formed a partnership with this biotech company. It's not in the FDA Orange book because these in-licensing agreements tend to happen during the Phase II clinical trial stage. I'll try to check on this at work, but I would imagine it will be a while before we see Phase III results.
|
I am sure if it was a cholesterol related drug they would express the approval of this.
__________________
Diagnosis: Idiopathic Small Fiber Neuropathy (Statin Induced)
• R-Lipoic Acid: 100mg - 300mg Daily
• Acetyl-L Carnitine: 1500mg Daily
• Vitamin B12: 1000 mcg Daily
• Magnesium 500mg Daily
• Grape Seed Extract 200mg Daily
• Benfotiamine 300mg daily